BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Retina
,
Amniocentesis
,
Aspirin
,
rs3825942
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
radiopharmaceuticals
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Determinants of FDG-retention in cancer cell lines and primary human tumors
Broad Connectivity Map (CMAP 2.0) compound database
Thyroid tissues after exposure to different doses of astatine-211 (211At) alpha particles
Explore Curated Studies Results
Literature
Most Relevant Literature
Automated preparation of radiopharmaceuticals as a tool of radiation protection optimisation of staf…
Radiopharmaceuticals for Treatment of Osteosarcoma.
Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.
Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnai…
Systematic Assessment of the Adsorption of 99mTc-Radiopharmaceuticals onto Plastic Syringes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Preparation of Radiopharmaceuticals by Automaton: Operators Dosimetry
Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial Imaging(Rb-ARMI)
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
[18F]-F13640 as a New Brain Radiopharmaceutical
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ